Skip to main content
Literatur
1.
Zurück zum Zitat Beetz R, Wagenlehner F (2013) Diagnostik und Therapie von Harnwegsinfektionen. Urologe 52(1):21–32CrossRefPubMed Beetz R, Wagenlehner F (2013) Diagnostik und Therapie von Harnwegsinfektionen. Urologe 52(1):21–32CrossRefPubMed
2.
Zurück zum Zitat Carlsen NL et al (1985) Comparison of long-term, low-dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in children. An open, randomized, cross-over study. J Antimicrob Chemother 16(4):509–517CrossRefPubMed Carlsen NL et al (1985) Comparison of long-term, low-dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in children. An open, randomized, cross-over study. J Antimicrob Chemother 16(4):509–517CrossRefPubMed
3.
Zurück zum Zitat Price E et al (2010) Microbiological aspects of the UK National Institute for Health and Clinical Excellence (NICE) guidance on urinary tract infection in children. J Antimicrob Chemother 65(5):836–841CrossRefPubMed Price E et al (2010) Microbiological aspects of the UK National Institute for Health and Clinical Excellence (NICE) guidance on urinary tract infection in children. J Antimicrob Chemother 65(5):836–841CrossRefPubMed
4.
Zurück zum Zitat Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB (2011) Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128(3):595–610CrossRef Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB (2011) Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128(3):595–610CrossRef
5.
6.
Zurück zum Zitat Salomonsson P et al (2016) Best oral empirical treatment for pyelonephritis in children: Do we need to differentiate between age and gender? Infect Dis (Lond) 48(10):721–725CrossRef Salomonsson P et al (2016) Best oral empirical treatment for pyelonephritis in children: Do we need to differentiate between age and gender? Infect Dis (Lond) 48(10):721–725CrossRef
7.
Zurück zum Zitat Linhares I et al (2013) Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009). BMC Infect Dis 13:19CrossRefPubMedPubMedCentral Linhares I et al (2013) Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009). BMC Infect Dis 13:19CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Abelson Storby K et al (2004) Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis. Acta Paediatr 93(4):487–491CrossRefPubMed Abelson Storby K et al (2004) Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis. Acta Paediatr 93(4):487–491CrossRefPubMed
9.
Zurück zum Zitat Hof H et al (2017) Nitroxolin – eine Option zur antibiotischen Therapie von Harnwegsinfektionen. Urologe 56(2):167–171CrossRefPubMed Hof H et al (2017) Nitroxolin – eine Option zur antibiotischen Therapie von Harnwegsinfektionen. Urologe 56(2):167–171CrossRefPubMed
10.
Zurück zum Zitat Principi N et al (1990) Fosfomycin trometamol versus netilmicin in children’s lower urinary tract infections. Chemotherapy 36(Suppl 1):41–45CrossRefPubMed Principi N et al (1990) Fosfomycin trometamol versus netilmicin in children’s lower urinary tract infections. Chemotherapy 36(Suppl 1):41–45CrossRefPubMed
11.
Zurück zum Zitat Jodal U (1992) The role of fosfomycin trometamol in the management of urinary tract infections in pediatrics. Infection 20(Suppl 4):S317–320CrossRefPubMed Jodal U (1992) The role of fosfomycin trometamol in the management of urinary tract infections in pediatrics. Infection 20(Suppl 4):S317–320CrossRefPubMed
12.
Zurück zum Zitat Calzi A et al (2016) Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children. Eur J Pediatr 175(9):1219–1222CrossRefPubMed Calzi A et al (2016) Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children. Eur J Pediatr 175(9):1219–1222CrossRefPubMed
14.
Zurück zum Zitat Singer S et al (2013) Kalkulierte Antibiotikatherapie von Harnwegsinfektionen bei älteren Frauen. Gynakologe 11:847–857CrossRef Singer S et al (2013) Kalkulierte Antibiotikatherapie von Harnwegsinfektionen bei älteren Frauen. Gynakologe 11:847–857CrossRef
15.
Zurück zum Zitat Wu TH et al (2016) Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux. J Microbiol Immunol Infect 49(5):717–722CrossRefPubMed Wu TH et al (2016) Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux. J Microbiol Immunol Infect 49(5):717–722CrossRefPubMed
16.
Zurück zum Zitat Bleidorn J et al (2016) Recurrent urinary tract infections and complications after symptomatic versus antibiotic treatment: follow-up of a randomised controlled trial. Ger Med Sci 14:Doc01PubMedPubMedCentral Bleidorn J et al (2016) Recurrent urinary tract infections and complications after symptomatic versus antibiotic treatment: follow-up of a randomised controlled trial. Ger Med Sci 14:Doc01PubMedPubMedCentral
17.
Zurück zum Zitat Hof H (2016) Harnwegsinfektionen – Teil 3: Prävention. GYN (Omnimed Verlag) 21:20–24 Hof H (2016) Harnwegsinfektionen – Teil 3: Prävention. GYN (Omnimed Verlag) 21:20–24
18.
Zurück zum Zitat Palleschi G et al (2017) Prospective study to compare antibiosis versus the association of N‑acetylcysteine, D‑mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Arch Ital Urol Androl 89:45–50CrossRefPubMed Palleschi G et al (2017) Prospective study to compare antibiosis versus the association of N‑acetylcysteine, D‑mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation. Arch Ital Urol Androl 89:45–50CrossRefPubMed
Metadaten
Titel
Anmerkungen zur Therapie und Prävention von Harnwegsinfektionen bei Kindern
verfasst von
Prof. Dr. H. Hof
Publikationsdatum
30.06.2017
Verlag
Springer Medizin
Erschienen in
Die Urologie / Ausgabe 10/2017
Print ISSN: 2731-7064
Elektronische ISSN: 2731-7072
DOI
https://doi.org/10.1007/s00120-017-0430-4

Weitere Artikel der Ausgabe 10/2017

Der Urologe 10/2017 Zur Ausgabe

Termine

Termine

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.